PRODUCTION OF INTERFERON BY HUMAN MONONUCLEAR LEUCOCYTES.
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to S H LEE.
Explore the source record for details and available documents.
Lee, Spencer H. S. (Dalhousie University, Halifax, Nova Scotia). Effect of 6-aminonicotinamide on chick-embryo tissue cultures infected with vaccinia virus. J. Bacteriol. 88:885-892. 1964.-6-Aminonicotinamide (6-AN) was shown to render chick-embryo fibroblast (CEF) tissue cultures refractory to infection with vaccinia virus. Pretreatment of CEF cultures for 8 hr at 36 C with 5 mug/ml of 6-AN prior to addition of vaccinia virus reduced the titer of active virus to about 0.4% of the levels obtained in the untreated controls, when measured by the number of plaque-forming units per milliliter. The addition of 5 mug of 6-AN to CEF cultures before virus infection retarded the progress of vaccinial infection by 8 to 10 hr at 36 C. The inhibitory effect caused by 5 mug/ml of 6-AN could be reversed by the simultaneous addition of 5 to 50 mug/ml of nicotinamide, but not if added at a later time. 6-AN appears to act on the host cell and not on vaccinia virus. For these tests, a simple plaque assay method was devised, by use of a fluid overlay technique with screw-capped tubes (16 by 125 mm) containing CEF cultures.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.